{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:47:58Z","timestamp":1791946078940,"version":"4.3.4"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T00:00:00Z","timestamp":1677196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["18B2721N, 1831512N"],"award-info":[{"award-number":["18B2721N, 1831512N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Chemokine research offers insightful information on the pathogenesis of cutaneous immune disorders, such as vitiligo. Compared to cytokines, the higher detectable levels of chemokines display promising potential as future disease biomarkers. Nonetheless, some published study results are contradictory, which can be attributed to patient characteristics and methodological differences. In this study, a meta-analysis was performed to compare chemokine expression in blood and skin samples from vitiligo patients versus healthy controls. Furthermore, the relationship between chemokine expression and disease activity was evaluated. Chemokine levels were investigated in 15 articles in the circulation and in 9 articles in vitiligo skin. Overall, some clear trends were observed. CXCR3 signaling by CXCL10 and CXCL9 has been confirmed by several reports, although CXCL10 showed more robust findings in blood samples. In this meta-analysis, CCL5, CXCL8, CXCL12, and CXCL16 levels were also significantly elevated. This indicates a complex immune pathway activation in vitiligo that overall supports a Th1-dominant response. Chemokines linked to the Th2 and Th17 pathways were less prevalent. Despite these findings, study protocols that examine a broader range of chemokines are encouraged, because current research is mostly focused on a small number of chemokines that were differentially expressed in previous studies.<\/jats:p>","DOI":"10.3389\/fimmu.2023.1112811","type":"journal-article","created":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T12:05:47Z","timestamp":1677240347000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":45,"title":["A meta-analysis of chemokines in vitiligo: Recruiting immune cells towards melanocytes"],"prefix":"10.3389","volume":"14","author":[{"given":"Reinhart","family":"Speeckaert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arno","family":"Belpaire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marijn M.","family":"Speeckaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanja","family":"van Geel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,2,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2018.02.012","article-title":"Chemokines beyond chemo-attraction: CXCL10 and its significant role in cancer and autoimmunity","volume":"109","author":"Karin","year":"2018","journal-title":"Cytokine"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/s1568-9972(02)00085-x","article-title":"Chemokines in autoimmunity: From pathology to therapeutics","volume":"1","author":"Kunkel","year":"2002","journal-title":"Autoimmun Rev"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.1102577","article-title":"Expression and function of chemokines during viral infections: from molecular mechanisms to in vivo function","volume":"74","author":"Melchjorsen","year":"2003","journal-title":"J Leukoc Biol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1177\/0962280216669183","article-title":"Optimally estimating the sample mean from the sample size, median, mid-range, and\/or mid-quartile range","volume":"27","author":"Luo","year":"2018","journal-title":"Stat Methods Med Res"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.1481","article-title":"Extracting data from graphs: A case-study on animal research with implications for meta-analyses","volume":"12","author":"Van der Mierden","year":"2021","journal-title":"Res Synthesis Methods"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2018.00271","article-title":"The role of CXCR3 and its chemokine ligands in skin disease and cancer","volume":"5","author":"Kuo","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"B8","first-page":"91","article-title":"CXC chemokines in cancer angiogenesis and metastases","volume-title":"Adv Cancer Res","author":"Keeley","year":"2010"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01970","article-title":"Overview of the mechanisms that may contribute to the non-redundant activities of interferon-inducible CXC chemokine receptor 3 ligands","volume":"8","author":"Metzemaekers","year":"2017","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/imm.13200","article-title":"Understanding the mechanisms that facilitate specificity, not redundancy, of chemokine-mediated leukocyte recruitment","volume":"160","author":"Dyer","year":"2020","journal-title":"Immunology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1038\/s41467-019-09963-8","article-title":"Innate lymphocyte-induced CXCR3B-mediated melanocyte apoptosis is a potential initiator of T-cell autoreactivity in vitiligo","volume":"10","author":"Tulic","year":"2019","journal-title":"Nat Commun"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2017.11.007","article-title":"CXCL9, CXCL10, CXCL11\/CXCR3 axis for immune activation - a target for novel cancer therapy","volume":"63","author":"Tokunaga","year":"2018","journal-title":"Cancer Treat Rev"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.14004","article-title":"Role of chemokines and the corresponding receptors in vitiligo: A pilot study","volume":"45","author":"Yang","year":"2018","journal-title":"J Dermatol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/pcmr.12559","article-title":"Differential expression of CXCL9, CXCL10, and IFN-\u03b3 in vitiligo and alopecia areata patients","volume":"30","author":"Maouia","year":"2017","journal-title":"Pigment Cell Melanoma Res"},{"key":"B15","doi-asserted-by":"publisher","first-page":"393","DOI":"10.5021\/ad.2019.31.4.393","article-title":"Increased circulating CXCL10 in non-segmental vitiligo concomitant with autoimmune thyroid disease and alopecia areata","volume":"31","author":"Zhang","year":"2019","journal-title":"Ann Dermatol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"18298","DOI":"10.1038\/s41598-021-97296-2","article-title":"CXCL9 as a key biomarker of vitiligo activity and prediction of the success of cultured melanocyte transplantation","volume":"11","author":"Lin","year":"2021","journal-title":"Sci Rep"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2017.03.008","article-title":"A similar local immune and oxidative stress phenotype in vitiligo and halo nevus","volume":"87","author":"Yang","year":"2017","journal-title":"J Dermatol Sci"},{"key":"B18","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.jaad.2016.12.021","article-title":"Suction blistering the lesional skin of vitiligo patients reveals useful biomarkers of disease activity","volume":"76","author":"Strassner","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.872458","article-title":"Skin interstitial fluid and plasma multiplex cytokine analysis reveals IFN-\u03b3 signatures and granzyme b as useful biomarker for activity, severity and prognosis assessment in vitiligo","volume":"13","author":"Ng","year":"2022","journal-title":"Front Immunol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.jaci.2016.10.013","article-title":"Oxidative stress drives CD8+ T-cell skin trafficking in patients with vitiligo through CXCL16 upregulation by activating the unfolded protein response in keratinocytes","volume":"140","author":"Li","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"397","DOI":"10.5114\/ada.2022.115891","article-title":"Assessment of ADAM17 and ADAM10 proteins with CXCL10 and thyroid autoimmunity in vitiligo pathogenesis","volume":"39","author":"K\u0131l\u0131c","year":"2022","journal-title":"Postepy Dermatol Alergol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14416","article-title":"Increased expression of CXCR3 and its ligands in patients with vitiligo and CXCL10 as a potential clinical marker for vitiligo","volume":"174","author":"Wang","year":"2016","journal-title":"Br J Dermatol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"223ra23","DOI":"10.1126\/scitranslmed.3007811","article-title":"CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo","volume":"6","author":"Rashighi","year":"2014","journal-title":"Sci Transl Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1111\/pcmr.12219","article-title":"Type I interferon signature in the initiation of the immune response in vitiligo","volume":"27","author":"Bertolotti","year":"2014","journal-title":"Pigment Cell Melanoma Res"},{"key":"B25","first-page":"27","article-title":"Chemokines in vitiligo pathogenesis: CXCL10 and 12","volume":"14","author":"Gharib","year":"2021","journal-title":"J Clin Aesthet Dermatol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-021-02228-9","article-title":"Systemic CXCL10 is a predictive biomarker of vitiligo lesional skin infiltration, PUVA, NB-UVB and corticosteroid treatment response and outcome","volume":"314","author":"El-Domyati","year":"2022","journal-title":"Arch Dermatol Res"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1111\/pcmr.12667","article-title":"CXCL-10 and interleukin-6 are reliable serum markers for vitiligo activity: A multicenter cross-sectional study","volume":"31","author":"Abdallah","year":"2018","journal-title":"Pigment Cell Melanoma Res"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2017.07.006","article-title":"Circulating CXCL10 is increased in non-segmental vitiligo, in presence or absence of autoimmune thyroiditis","volume":"16","author":"Ferrari","year":"2017","journal-title":"Autoimmun Rev"},{"key":"B29","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1002\/1096-9896(200108)194:4<397::aid-path899>3.0.co;2-s","article-title":"Differential expression of CXCR3 targeting chemokines CXCL10, CXCL9, and CXCL11 in different types of skin inflammation","volume":"194","author":"Flier","year":"2001","journal-title":"J Pathol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12103071","article-title":"The signaling duo CXCL12 and CXCR4: Chemokine fuel for breast cancer tumorigenesis","volume":"12","author":"Zieli\u0144ska","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2008.08.014","article-title":"CXCL12 induction of iNOS in human CD8 T cells","volume":"27","author":"Choy","year":"2008","journal-title":"J Heart Lung Transplant"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18122533","article-title":"Differential expression of nitric oxide synthase isoforms nNOS and iNOS in patients with non-segmental generalized vitiligo","volume":"18","author":"Vaccaro","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2017.02.012","article-title":"Alterations of CXCL12 in serum of patients with vitiligo","volume":"137","author":"Speeckaert","year":"2017","journal-title":"J Invest Dermatol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00585","article-title":"The role of the CXCL12\/CXCR4\/ACKR3 axis in autoimmune diseases","volume":"10","author":"Garc\u00eda-Cuesta","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1111\/exd.13908","article-title":"Differential expression of inflammatory cytokines and chemokines in lipopolysaccharide-stimulated melanocytes from lightly and darkly pigmented skin","volume":"28","author":"Tam","year":"2019","journal-title":"Exp Dermatol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2016.12.028","article-title":"Misbalanced CXCL12 and CCL5 chemotactic signals in vitiligo onset and progression","volume":"137","author":"Rezk","year":"2017","journal-title":"J Invest Dermatol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1109\/TCBB.2018.2835459","article-title":"A parametric targetability evaluation approach for vitiligo proteome extracted through integration of gene ontologies and protein interaction topologies","volume":"16","author":"Malhotra","year":"2019","journal-title":"IEEE\/ACM Trans Comput Biol Bioinform"},{"key":"B38","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s00403-018-1880-2","article-title":"CXCL12 regulates differentiation of human immature melanocyte precursors as well as their migration","volume":"311","author":"Yamada","year":"2019","journal-title":"Arch Dermatol Res"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1097\/CM9.0000000000001689","article-title":"Pro-pigmentary action of 5-fluorouracil through the stimulated secretion of CXCL12 by dermal fibroblasts","volume":"134","author":"Liao","year":"2021","journal-title":"Chin Med J"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.37506\/ijphrd.v11i3.3945","article-title":"Evaluation of serum level of RANTES among vitiligo patients before and after treatment by fractional carbon dioxide laser","volume":"11","author":"Shokeir1","year":"2020","journal-title":"Indian J Public Health Res Dev"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/s1471-4906(00)01812-3","article-title":"RANTES: A versatile and controversial chemokine","volume":"22","author":"Appay","year":"2001","journal-title":"Trends Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abd8995","article-title":"scRNA-seq of human vitiligo reveals complex networks of subclinical immune activation and a role for CCR5 in treg function","volume":"13","author":"Gellatly","year":"2021","journal-title":"Sci Transl Med"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.7150\/thno.15625","article-title":"Role of the CXCL8-CXCR1\/2 axis in cancer and inflammatory diseases","volume":"7","author":"Ha","year":"2017","journal-title":"Theranostics"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-03-1067","article-title":"IL-8 responsiveness defines a subset of CD8 T cells poised to kill","volume":"104","author":"Hess","year":"2004","journal-title":"Blood"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.e07-01-0004","article-title":"Transactivation of vascular endothelial growth factor receptor-2 by interleukin-8 (IL-8\/CXCL8) is required for IL-8\/CXCL8-induced endothelial permeability","volume":"18","author":"Petreaca","year":"2007","journal-title":"Mol Biol Cell"},{"key":"B46","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jdermsci.2018.12.005","article-title":"Circulating CCL20: A potential biomarker for active vitiligo together with the number of Th1\/17 cells","volume":"93","author":"Zhang","year":"2019","journal-title":"J Dermatol Sci"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.37506\/ijfmt.v15i3.15468","article-title":"Serum level of CCL20 and CXCL 10 in patients with vitiligo and their association with disease activity","volume":"15","author":"AL-Mousawi","year":"2021","journal-title":"Indian J Forensic Med Toxicol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"3158","DOI":"10.1016\/j.jid.2022.05.1090","article-title":"Regulatory T cells require CCR6 for skin migration and local suppression of vitiligo","volume":"142","author":"Essien","year":"2022","journal-title":"J Invest Dermatol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1155\/2009\/193970","article-title":"Interleukin (IL)-4 induces leukocyte infiltration in vivo by an indirect mechanism","volume":"2009","author":"Ratth\u00e9","year":"2009","journal-title":"Mediators Inflammation"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.042671","article-title":"CCL2 and interleukin-6 promote survival of human CD11b+ peripheral blood mononuclear cells and induce M2-type macrophage polarization *","volume":"284","author":"Roca","year":"2009","journal-title":"J Biol Chem"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1007\/978-94-007-7696-8_27","article-title":"Macrophage inflammatory protein-1 alpha (MIP-1 alpha)\/CCL3: As a biomarker","author":"Bhavsar","year":"2015","journal-title":"Gen Methods biomark Res their Appl"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1111\/ced.13961","article-title":"Comprehensive lipidomic, metabolomic and proteomic profiling reveals the role of immune system in vitiligo","volume":"44","author":"Liang","year":"2019","journal-title":"Clin Exp Dermatol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1112811\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T12:05:53Z","timestamp":1677240353000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1112811\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,24]]},"references-count":52,"alternative-id":["10.3389\/fimmu.2023.1112811"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1112811","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,24]]},"article-number":"1112811"}}